[THE INVESTOR] The Korean unit of Swiss drug giant Novartis was slapped with a 55.1 billion won (US$48.80 million) fine and insurance coverage suspensions for giving illegal kickbacks to doctors in Korea.On April 27, Korea's Health Ministry made the preliminary decision that will be finalized in May following further consulations with the company. Of the 42 rebate-related Novartis products, nine variants of two drugs -- Alzheimer’s drug Exelon and bone cancer treatment Zometa -- will not be cove
  • KOSPI 2207.84 ▲10.99
  • KOSDAQ 628.24 ▼-2.87
  • USD/KRW 1137.00 ▲3.00
  • CNH/KRW 164.78 ▲0.44
  • DUBAI 49.87
  • TB(3Year) 1.675
이전 다음